Fig 7. Pretreatment of naringenin prevented cholinergic dysfunctions in AD-like animal model.
(A) Acetylcholine levels in hippocampus and (B) in cortex. (C) Acetylcholinesterase activity in hippocampus and (D) in cortex. Data is presented as mean ± SD (n = 6). Data was analyzed by post-hoc analysis following one way ANOVA. Significant differences were obtained *p<0.05, **p<0.01 from control rats; ++p<0.01 from AD-like model rats.